Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Definitive Healthcare Corp (NASDAQ: DH) closed the day trading at $2.52 down -0.40% from the previous closing price of $2.53. In other words, the price has decreased by -$0.40 from its previous closing price. On the day, 0.62 million shares were traded. DH stock price reached its highest trading level at $2.55 during the session, while it also had its lowest trading level at $2.4.
Ratios:
For a better understanding of DH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.92 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.91. For the most recent quarter (mrq), Quick Ratio is recorded 1.52 and its Current Ratio is at 1.52. In the meantime, Its Debt-to-Equity ratio is 0.62 whereas as Long-Term Debt/Eq ratio is at 0.58.
On January 13, 2025, Barclays Downgraded its rating to Underweight which previously was Equal Weight but kept the price unchanged to $4. On December 20, 2024, Stephens started tracking the stock assigning a Equal-Weight rating and target price of $5.Stephens initiated its Equal-Weight rating on December 20, 2024, with a $5 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DH now has a Market Capitalization of 262297248 and an Enterprise Value of 354617536. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.47 while its Price-to-Book (P/B) ratio in mrq is 0.91. Its current Enterprise Value per Revenue stands at 1.464 whereas that against EBITDA is 8.481.
Stock Price History:
The Beta on a monthly basis for DH is 1.61, which has changed by -0.40470588 over the last 52 weeks, in comparison to a change of 0.13927746 over the same period for the S&P500. Over the past 52 weeks, DH has reached a high of $5.68, while it has fallen to a 52-week low of $2.15. The 50-Day Moving Average of the stock is -6.49%, while the 200-Day Moving Average is calculated to be -23.27%.
Shares Statistics:
Over the past 3-months, DH traded about 366.84K shares per day on average, while over the past 10 days, DH traded about 749900 shares per day. A total of 103.01M shares are outstanding, with a floating share count of 29.19M. Insiders hold about 71.74% of the company’s shares, while institutions hold 32.03% stake in the company. Shares short for DH as of 1764288000 were 3228859 with a Short Ratio of 8.80, compared to 1761868800 on 3610061. Therefore, it implies a Short% of Shares Outstanding of 3228859 and a Short% of Float of 8.189999.
Earnings Estimates
. The current rating of Definitive Healthcare Corp (DH) reflects the combined expertise of 12.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.06, with high estimates of $0.08 and low estimates of $0.04.
Analysts are recommending an EPS of between $0.31 and $0.23 for the fiscal current year, implying an average EPS of $0.24. EPS for the following year is $0.26, with 12.0 analysts recommending between $0.34 and $0.2.
Revenue Estimates
11 analysts predict $59.39M in revenue for. The current quarter. It ranges from a high estimate of $59.8M to a low estimate of $57.93M. As of. The current estimate, Definitive Healthcare Corp’s year-ago sales were $62.29MFor the next quarter, 11 analysts are estimating revenue of $57.45M. There is a high estimate of $59.19M for the next quarter, whereas the lowest estimate is $56.33M.
A total of 11 analysts have provided revenue estimates for DH’s current fiscal year. The highest revenue estimate was $239.8M, while the lowest revenue estimate was $239.4M, resulting in an average revenue estimate of $239.52M. In the same quarter a year ago, actual revenue was $252.2MBased on 12 analysts’ estimates, the company’s revenue will be $233.9M in the next fiscal year. The high estimate is $241.61M and the low estimate is $229.92M.
